Researchers recently discovered that eight different psychiatric conditions share a common genetic basis.

New diagnoses of disorders including psychosis, dementia, seizures and ‘brain fog’ remain commoner two years after COVID-19 than after other respiratory infections, whereas the increased risks of

Large-scale longitudinal health records reveal consistent association of varicella-zoster virus reactivation with dementia.

The first results of DecodeME are in, the largest research project ever undertaken on myalgicContinue readingDecodeME: the biggest ME/CFS study ever

Record solar expansion and steady wind growth driving world’s shift away from fossil fuels in 2025, report finds

Human-associated microbes hold immense therapeutic potential, yet most species remain undomesticated due to cultivation barriers and limited genetic t…

YouTube video by Loreena McKennitt - Topic

The infection rate of one type of carbapenem-resistant Enterobacterales bacteria has risen by more than 460 percent in recent years. Scientists say people receiving treatment in hospitals are at highe...

Antimicrobial resistance (AMR) is an emerging public health threat. In North America, tetracycline and macrolide antibiotics are often used to prevent or treat bacterial infections in honey bees. Prev...

YouTube video by Scott Santens

The Harvard academic Andrea Baccarelli gave an ‘unreliable’ testimony on the links between autism and paracetamol, and produced research that raises ‘serious concerns about bias’

How false testimony about Tylenol and autism failed in court, was repackaged as “peer-reviewed” junk science, and is now driving Trump’s dangerous medical advice.

Most variants aren’t proven to be harmful.

'I'm really concerned about how this message is going to play out,' one researcher said

Large language models (LLMs) are playing an increasingly integral, though largely informal, role in scholarly peer review. Yet it remains unclear whether LLMs reproduce the biases observed in human de...

This Perspective explores recent progress and future directions in glucagon-like peptide-1 medicines.